litlas
ログインアカウント作成

Keith Wheatley

1988–2025 年に発表

122
論文数
36,378
被引用数
89
h 指数
119
i10 指数

被引用数

Keith Wheatley の年別被引用数1977 年: 被引用 2 件1978 年: 被引用 5 件1979 年: 被引用 7 件1980 年: 被引用 5 件1981 年: 被引用 3 件1982 年: 被引用 3 件1983 年: 被引用 10 件1984 年: 被引用 10 件1985 年: 被引用 12 件1986 年: 被引用 13 件1987 年: 被引用 8 件1988 年: 被引用 10 件1989 年: 被引用 24 件1990 年: 被引用 13 件1991 年: 被引用 15 件1992 年: 被引用 25 件1993 年: 被引用 15 件1994 年: 被引用 14 件1995 年: 被引用 30 件1996 年: 被引用 42 件1997 年: 被引用 67 件1998 年: 被引用 86 件1999 年: 被引用 103 件2000 年: 被引用 114 件2001 年: 被引用 159 件2002 年: 被引用 220 件2003 年: 被引用 252 件2004 年: 被引用 202 件2005 年: 被引用 274 件2006 年: 被引用 270 件2007 年: 被引用 269 件2008 年: 被引用 278 件2009 年: 被引用 311 件2010 年: 被引用 309 件2011 年: 被引用 313 件2012 年: 被引用 356 件2013 年: 被引用 317 件2014 年: 被引用 334 件2015 年: 被引用 288 件2016 年: 被引用 294 件2017 年: 被引用 209 件2018 年: 被引用 220 件2019 年: 被引用 819 件2020 年: 被引用 694 件2021 年: 被引用 744 件2022 年: 被引用 422 件2023 年: 被引用 352 件2024 年: 被引用 497 件2025 年: 被引用 201 件2026 年: 被引用 2 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,031 件、この内訳の 23.3%イギリス: 引用元論文 1,426 件、この内訳の 11%ドイツ: 引用元論文 994 件、この内訳の 7.6%イタリア: 引用元論文 870 件、この内訳の 6.7%フランス: 引用元論文 665 件、この内訳の 5.1%オランダ: 引用元論文 539 件、この内訳の 4.1%中国: 引用元論文 479 件、この内訳の 3.7%カナダ: 引用元論文 445 件、この内訳の 3.4%オーストラリア: 引用元論文 413 件、この内訳の 3.2%スペイン: 引用元論文 398 件、この内訳の 3.1%スウェーデン: 引用元論文 306 件、この内訳の 2.4%スイス: 引用元論文 282 件、この内訳の 2.2%
0%23.3%その他 24.2%

機関

分野

  • Medicine82.3%
  • Biochemistry, Genetics and Molecular Biology8.6%
  • Health Professions2.7%
  • Immunology and Microbiology1.5%
  • Social Sciences0.8%
  • Neuroscience0.8%
  • その他3.3%

トピック

  • Acute Myeloid Leukemia Research11.8%
  • Acute Lymphoblastic Leukemia research3.8%
  • Myeloproliferative Neoplasms: Diagnosis and Treatment3.8%
  • Chronic Myeloid Leukemia Treatments2.9%
  • Smoking Behavior and Cessation2.8%
  • Hematopoietic Stem Cell Transplantation2.7%
  • その他72.2%

共著者

全論文

検索で開く
  1. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials

    著者: David Grimwade, Robert K. Hills, Anthony V. Moorman, Helen M. Walker, S Chatters, Anthony H. Goldstone, Keith Wheatley, Christine J. Harrison, Alan K. Burnett - Blood 2010 被引用: 1,951

  2. Mortality in relation to smoking: 40 years' observations on male British doctors

    著者: Richard Doll, Richard Peto, Keith Wheatley, Richard Gray, I. L. G. Sutherland - BMJ 1994 被引用: 5,773

  3. Augmented Reduced-Intensity Regimen Does Not Improve Postallogeneic Transplant Outcomes in Acute Myeloid Leukemia

    著者: Charles Craddock, Aimee Jackson, Justin Loke, Shamyla Siddique, Andrea Hodgkinson, John Mason, Georgia Andrew, Sandeep Nagra, Ram Malladi, Andrew Peniket, Maria Gilleece, Rahuman Salim, Eleni Tholouli, Victoria Potter, Charles Crawley, Keith Wheatley, Rachel Protheroe, Paresh Vyas, Ann Hunter, Anne Parker, Keith Wilson, Jiří Pavlů, Jenny Byrne, Richard Dillon, Naeem Khan, Nicholas McCarthy, Sylvie Freeman - Journal of Clinical Oncology 2020 被引用: 165

  4. Rituximab for High-Risk, Mature B-Cell Non-Hodgkin’s Lymphoma in Children

    著者: Véronique Minard‐Colin, Anne Aupérin, Marta Pillon, G.A. Amos Burke, Donald A. Barkauskas, Keith Wheatley, Rafael F. Delgado, Sarah Alexander, Anne Uyttebroeck, Catherine M. Bollard, József Zsíros, Monika Csóka, Bernarda Kazanowska, Aks Chiang, Rodney R. Miles, Andrew Wotherspoon, Peter C. Adamson, Gilles Vassal, Catherine Patte, Thomas G. Gross - New England Journal of Medicine 2020 被引用: 312

  5. Minimal residual disease monitoring by quantitative RT-PCR in core binding factor AML allows risk stratification and predicts relapse: results of the United Kingdom MRC AML-15 trial

    著者: John A. Liu Yin, Michelle A. O'Brien, Robert K. Hills, Sarah B. Daly, Keith Wheatley, Alan K. Burnett - Blood 2012 被引用: 419

  6. The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials

    著者: Panagiotis Kottaridis, Rosemary E. Gale, Marion E. Frew, G Harrison, Stephen E. Langabeer, Andrea A. Belton, Helen M. Walker, Keith Wheatley, David Bowen, Alan K. Burnett, Anthony H. Goldstone, David C. Linch - Blood 2001 被引用: 1,538

  7. Optimization of Chemotherapy for Younger Patients With Acute Myeloid Leukemia: Results of the Medical Research Council AML15 Trial

    著者: Alan K. Burnett, Nigel H. Russell, Robert K. Hills, Ann E. Hunter, Lars Kjeldsen, John Liu Yin, Brenda Gibson, Keith Wheatley, Donald Milligan - Journal of Clinical Oncology 2013 被引用: 415

  8. Association between premature mortality and hypopituitarism

    著者: Jeremy Tomlinson, N Holden, Robert K. Hills, Keith Wheatley, RN Clayton, AS Bates, MC Sheppard, PM Stewart - The Lancet 2001 被引用: 1,009

  9. Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial

    著者: Adrian C. Williams, Steven R. Gill, Thelekat R. K. Varma, Crispin Jenkinson, Niall Quinn, Rosalind Mitchell, Richard Scott, Natalie Ives, Caroline Rick, Jane Daniels, Smitaa Patel, Keith Wheatley - The Lancet Neurology 2010 被引用: 729

  10. Efficiency and safety of varying the frequency of whole blood donation (INTERVAL): a randomised trial of 45 000 donors

    著者: Emanuele Di Angelantonio, Simon G. Thompson, Stephen Kaptoge, Carmel Moore, Matthew R. Walker, Jane Armitage, Willem H. Ouwehand, David J. Roberts, John Danesh, Emanuele Di Angelantonio, Simon G. Thompson, Stephen Kaptoge, Carmel Moore, Matthew R. Walker, Jane Armitage, Willem H. Ouwehand, David J. Roberts, John Danesh, Jane Armitage, John Danesh, Emanuele Di Angelantonio, Jenny Donovan, Ian Ford, Rachel Henry, Beverley J. Hunt, Bridget le Huray, Susan Mehenny, Gail Miflin, Carmel Moore, Willem H. Ouwehand, Jane Green, David J. Roberts, Mike Stredder, Simon G. Thompson, Matthew R. Walker, Nicholas A. Watkins, Alan McDermott, Clive Ronaldson, Claire Thomson, Zoe Tolkien, Lorna M. Williamson, David L. Allen, John Danesh, Emanuele Di Angelantonio, Rachel Henry, Susan Mehenny, Carmel Moore, Willem H. Ouwehand, David J. Roberts, Jennifer Sambrook, Matthew R. Walker, Tracey Hammerton, Claire Thomson, Zoe Tolkien, David L. Allen, David Bruce, Fizzah Choudry, Emanuele Di Angelantonio, Cédric Ghevaert, Kirstie Johnston, Anne M. Kelly, Andrew King, Susan Mehenny, Gail Miflin, Alfred Mo, Carmel Moore, Willem H. Ouwehand, Lizanne Page, Penny Richardson, David J. Roberts, Jennifer Sambrook, Peter Senior, Yagnesh Umrania, Matthew R. Walker, Henna Wong, Stephen Kaptoge, Gavin J. Murphy, Adrian C. Newland, Keith Wheatley, M. Greaves, Marc Turner, Tahir Aziz, Richard A. Brain, Christine Davies, Ruth Turner, Paula Wakeman, Alison Dent, Alan Wakeman, Ben Anthony, Desmond Bland, Will Parrondo, Helen Vincent, Candy Weatherill, Andrea Forsyth, Carol Butterfield, Tracey Wright, Karen Ellis, Kirstie Johnston, Pat Poynton, Carolyn Brooks ほか 68 名 - The Lancet 2017 被引用: 299

  11. Bortezomib for the treatment of multiple myeloma

    著者: Kathleen M. Scott, Patrick Hayden, Andrea Will, Keith Wheatley, Imelda Coyne - Cochrane Database of Systematic Reviews 2016 被引用: 152

  12. Hydroxyurea Compared with Anagrelide in High-Risk Essential Thrombocythemia

    著者: Claire Harrison, Peter J. Campbell, Georgina Buck, Keith Wheatley, Clare East, D. Bareford, Bridget S. Wilkins, Jon van der Walt, John T. Reilly, Andrew Grigg, Paul Revell, Barrie Woodcock, Anthony R. Green - New England Journal of Medicine 2005 被引用: 921

  13. Identification of Patients With Acute Myeloblastic Leukemia Who Benefit From the Addition of Gemtuzumab Ozogamicin: Results of the MRC AML15 Trial

    著者: Alan K. Burnett, Robert K. Hills, Donald Milligan, Lars Kjeldsen, Jonathan Kell, Nigel H. Russell, John A. Liu Yin, Ann Hunter, Anthony H. Goldstone, Keith Wheatley - Journal of Clinical Oncology 2010 被引用: 652

  14. Comparison of two chemotherapy regimens in patients with newly diagnosed Ewing sarcoma (EE2012): an open-label, randomised, phase 3 trial

    著者: Bernadette Brennan, Laura Kirton, Perrine Marec‐Bérard, Nathalie Gaspar, Valérie Laurence, Javier Martín‐Broto, Ana Méndez‐Echevarría, Hans Gelderblom, Cormac Owens, Nicola Fenwick, Sandra J. Strauss, V. V. Moroz, Jeremy Whelan, Keith Wheatley - The Lancet 2022 被引用: 125

  15. Physiotherapy versus placebo or no intervention in Parkinson's disease

    著者: Claire L Tomlinson, Smitaa Patel, Charmaine Meek, Clare P Herd, Carl E Clarke, Rebecca Stowe, Laila Shah, Catherine Sackley, Katherine Deane, Keith Wheatley, Natalie Ives - Cochrane Database of Systematic Reviews 2013 被引用: 446

  16. Long-term Effectiveness of Adjuvant Treatment With Catechol-O-Methyltransferase or Monoamine Oxidase B Inhibitors Compared With Dopamine Agonists Among Patients With Parkinson Disease Uncontrolled by Levodopa Therapy

    著者: Richard Gray, Smitaa Patel, Natalie Ives, Caroline Rick, Rebecca Woolley, Sharon Muzerengi, Alastair Gray, Crispin Jenkinson, Emma McIntosh, Keith Wheatley, Adrian J. Williams, Carl E Clarke, PD MED Collaborative Group, Keith Young, Helen Price, Jonathan Price, Anne Lambert, Robin Reeve, M Sewell, Sally Broome, Adrian J. Williams, Mary Baker, Carl E Clarke, Ray Fitzpatrick, Alastair Gray, Richard Greenhall, Crispin Jenkinson, David Mant, Emma McIntosh, Peter Sandercock, Colin Baugent, Peter Crome, Pui Au, Thomas Boodell, Versha Cheed, Jane Daniels, Francis Dowling, Lorraine Evans, R J Hawker, Surinder Kaur, Caroline Rick, Keith Wheatley, Neil Winkles, David Hingley, Lauren Sturdy, Rebecca Wooley, Ryan Ottridge, Lisa Peto, Nicholas Hilken, Carl Counsell, Linda Caie, Robert Caslake, R. Coleman, Patrick M. Crowley, Linda M. Gerrie, Joanna Gordon, Clare Harris, V. Leslie, M. A. Macleod, Kate Taylor, Paul Worth, Roger A. Barker, Duncan R. Forsyth, M. Halls, John Young, Wendy Phillips, Mark Manford, N. Thangarajah, Debbie Blake, Richard Prescott, P. Carr, Lindy Cochrane, Angela Rose, Andrew McLaren, M. Drover, P. Mahinda Karunaratne, Amanda Eady, Magdalena Wislocka-Kryjak, Naveed Ghaus, A. Grueger, B. Mallinson, G. Wihl, S Ballantyne, Sharon Hutchinson, Alistair Lewthwaite, David Nicholl, Alistair Ritch, Sharon Coyle, R. W. Hornabrook, Hanan Irfan, S. Poxon, Uma Nath, James Davison, Sally Dodds, Gina Robinson, Carol Gray, Peter Fletcher, Philip Morrow, M. Sliva, Edmund Folkes ほか 226 名 - JAMA Neurology 2021 被引用: 60

  17. High-Dose Chemotherapy Compared With Standard Chemotherapy and Lung Radiation in Ewing Sarcoma With Pulmonary Metastases: Results of the European Ewing Tumour Working Initiative of National Groups, 99 Trial and EWING 2008

    著者: Uta Dirksen, Bernadette Brennan, Marie‐Cécile Le Deley, Nathalie Cozic, Henk van den Berg, Vivek A. Bhadri, Bénédicte Brichard, L. Claude, Alan Craft, Susanne Amler, Natalie Gaspar, Hans Gelderblom, Robert E. Goldsby, Richard Görlick, Holcombe E. Grier, Jean-Marc Guinbretiere, Péter Hauser, Lars Hjorth, Katherine A. Janeway, Heribert Juergens, Ian Judson, Mark Krailo, Jarmila Kruseová, Thomas Kuehne, Ruth Ladenstein, Cyril Lervat, Stephen L. Lessnick, Ian Lewis, Claude Linassier, Perrine Marec‐Bérard, Neyssa Marina, Bruce Morland, Hélène Pacquement, Michael Paulussen, R. Lor Randall, Andreas Ranft, Gwénaël Le Teuff, Keith Wheatley, Jeremy Whelan, Richard B. Womer, Odile Oberlin, Douglas S. Hawkins, on behalf of the Euro-E.W.I.N.G. 99 and Ewing 2008 Investigators - Journal of Clinical Oncology 2019 被引用: 145

  18. The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial

    著者: David Grimwade, Helen M. Walker, Fiona Oliver, Keith Wheatley, Christine J. Harrison, G Harrison, John Rees, Ian Hann, Richard Stevens, Alan K. Burnett, Anthony P. Goldstone - Blood 1998 被引用: 2,638

  19. Prospective Minimal Residual Disease Monitoring to Predict Relapse of Acute Promyelocytic Leukemia and to Direct Pre-Emptive Arsenic Trioxide Therapy

    著者: David Grimwade, Jelena Jovanović, Robert K. Hills, Elizabeth Nugent, Yashma Patel, Rajinder Flora, Daniela Diverio, Katy Jones, H. Aslett, Elaine Batson, Kristian Rennie, Roger Angell, Richard E. Clark, Ellen Solomon, Francesco Lo‐Coco, Keith Wheatley, Alan K. Burnett - Journal of Clinical Oncology 2009 被引用: 356

  20. Clinical effectiveness and cost-effectiveness of physiotherapy and occupational therapy versus no therapy in mild to moderate Parkinson’s disease: a large pragmatic randomised controlled trial (PD REHAB)

    著者: Carl E Clarke, Smitaa Patel, Natalie Ives, Caroline Rick, Rebecca Woolley, Keith Wheatley, Marion Walker, Shihua Zhu, Rebecca Kandiyali, Guiqing Yao, Catherine Sackley, on behalf of the PD REHAB Collaborative Group - Health Technology Assessment 2016 被引用: 107

  21. Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG)

    著者: Julia Chisholm, Henry Mandeville, Madeleine Adams, Veronique Minard-Collin, Timothy Rogers, Anna Kelsey, Janet Shipley, Rick R. van Rijn, Isabelle de Vries, Roelof van Ewijk, Bart de Keizer, Susanne A. Gatz, Michela Casanova, Lisa Lyngsie Hjalgrim, Charlotte Firth, Keith Wheatley, Pamela Kearns, Wenyu Liu, Amanda Kirkham, Helen Rees, Gianni Bisogno, Ajla Wasti, Sara Wakeling, Delphine Heenen, Deborah A. Tweddle, Johannes H. M. Merks, Meriel Jenney - Cancers 2024 被引用: 50

  22. Clinical Trials in High-Risk Medulloblastoma: Evolution of the SIOP-Europe HR-MB Trial

    著者: Simon Bailey, Nicolás André, Lorenza Gandola, Maura Massimino, Keith Wheatley, Simon Gates, Victoria Homer, Stefan Rutkowski, Steven C. Clifford - Cancers 2022 被引用: 47

  23. A comparison of low‐dose cytarabine and hydroxyurea with or without all‐trans retinoic acid for acute myeloid leukemia and high‐risk myelodysplastic syndrome in patients not considered fit for intensive treatment

    著者: Alan K. Burnett, Donald Milligan, Archie Prentice, Anthony H. Goldstone, Mary Frances McMullin, Robert K. Hills, Keith Wheatley - Cancer 2007 被引用: 616

  24. High-Dose Chemotherapy and Blood Autologous Stem-Cell Rescue Compared With Standard Chemotherapy in Localized High-Risk Ewing Sarcoma: Results of Euro-E.W.I.N.G.99 and Ewing-2008

    著者: Jeremy Whelan, Marie‐Cécile Le Deley, Uta Dirksen, Gwénaël Le Teuff, Bernadette Brennan, Nathalie Gaspar, Douglas S. Hawkins, Susanne Amler, Sebastian Bauer, Stefan Bielack, Jean‐Yves Blay, Stefan Burdach, Marie‐Pierre Castex, Dagmar Dilloo, Angelika Eggert, Hans Gelderblom, Jean‐Claude Gentet, Wolfgang Hartmann, Wolf-Achim Hassenpflug, Lars Hjorth, Marta Jimenez, Thomas Klingebiel, Udo Kontny, Jarmila Kruseová, Ruth Ladenstein, Valérie Laurence, Cyril Lervat, Perrine Marec‐Bérard, Sandrine Marréaud, Jean Michon, Bruce Morland, Michael Paulussen, Andreas Ranft, Peter Reichardt, Hendrik Van den Berg, Keith Wheatley, Ian Judson, Ian Lewis, Alan Craft, Heribert Juergens, Odile Oberlin, on behalf of the Euro-E.W.I.N.G.99 and EWING-2008 Investigators - Journal of Clinical Oncology 2018 被引用: 166